A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients

Affiliations

• ¹ Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China.
• ² Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, China.
• ³ Kidney Transplantation Dialysis Center, The Second People's Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China.
• ⁴ Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China.
• ⁵ Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China.
• ⁶ Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China.
• ⁷ Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China.
• ⁸ Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
• ⁹ Kidney Department, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China.
• ¹⁰ Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China.
• ¹¹ Department of Urology, Kidney Transplantation Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China.
• ¹² Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China.